InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Johnson Shane Aaron, Vice-Président. Director active across 1 company, notably InMed Pharmaceuticals Inc.. In total, 6 filings have been logged. Breakdown: 6 buys · 0 sell. Total volume traded: €50k. Activity tracked since 15 November 2021. The latest transaction was disclosed on 6 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
8,500 shares@ US$1.2638.0% of flowCommon StockSEC:0001213900-22-001005
Ideal exit: 3 Oct 2022 (T+270)
8,500 shares@ US$1.260.15% mcap19.0% of flowCommon StockSEC:0001213900-22-001005:0
Ideal exit: 3 Oct 2022 (T+270)
8,093 shares@ US$1.32660.15% mcap19.0% of flowCommon StockSEC:0001213900-21-068212:0
Ideal exit: 26 Sept 2022 (T+270)
8,093 shares@ US$1.326638.0% of flowCommon StockSEC:0001213900-21-068212
Ideal exit: 26 Sept 2022 (T+270)
5,000 shares@ US$1.3690.092% mcap12.0% of flowCommon StockSEC:0001213900-21-059271:0
Ideal exit: 12 Aug 2022 (T+270)
5,000 shares@ US$1.36924.0% of flowCommon StockSEC:0001213900-21-059271
Ideal exit: 12 Aug 2022 (T+270)
6 of 6 declarations
About Johnson Shane Aaron
Shane Aaron Johnson is Senior Vice President and General Manager of BayMedica LLC, a subsidiary of InMed Pharmaceuticals Inc. In this role, he oversees the operations and strategy of the company, ensuring growth and innovation.
